|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 39/39558 | (2013.01) | ||
| A61K 31/00 | (2006.01) | ||
| C07K 16/2827 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/337 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3506942 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17778387.5 |
| Date of filing the European patent application | 2017-08-31 | |
| (97) | Date of publication of the European application | 2019-07-10 |
| (45) | Date of publication and mention of the grant of the patent | 2022-11-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/049746 |
| Date | 2017-08-31 |
| (87) | Number | WO 2018/045239 |
| Date | 2018-03-08 |
| (30) | Number | Date | Country code |
| 201662382731 P | 2016-09-01 | US |
| (72) |
MARKOVIC, Svetomir N. , US
NEVALA, Wendy K. , US
|
| (73) |
Mayo Foundation for Medical Education and Research ,
200 First Street SW, Rochester, MN 55905,
US
|
| (54) | CARRIER-PD-L1 BINDING AGENT COMPOSITIONS FOR TREATING CANCERS |
| CARRIER-PD-L1 BINDING AGENT COMPOSITIONS FOR TREATING CANCERS |